Aktuellt
SENASTE
FDA has approved OssDsign Catalyst for use in interbody cages in spinal surgery. This will allow surgeons to use Catalyst on-label in the interbody space. Today a lot of the synthetic bone graft is believed to be used off-label which represents a risk to the hospital and surgeons. We view this news as very positive as it will most likely increase the number of hospital approvals which should lead to more users and larger volumes. Our mid-point of SEK 11 is under review.
LÄS MER
